Article
Oncology
Siang-Boon Koh, Kenneth Ross, Steven J. Isakoff, Nsan Melkonjan, Lei He, Karina J. Matissek, Andrew Schultz, Erica L. Mayer, Tiffany A. Traina, Lisa A. Carey, Hope S. Rugo, Minetta C. Liu, Vered Stearns, Adam Langenbucher, Srinivas Vinod Saladi, Sridhar Ramaswamy, Michael S. Lawrence, Leif W. Ellisen
Summary: This study identifies high levels of RASAL2 as predictors of chemotherapy response and long-term outcomes in TNBC. RASAL2 rewires MAPK feedback and cross-talk to confer resistance to MEK1/2 and EGFR inhibitors while also indicating sensitivity to these inhibitors.
CLINICAL CANCER RESEARCH
(2021)
Article
Biochemistry & Molecular Biology
Xue Yang, Miguel I. Cruz, Elizabeth V. Nguyen, Cheng Huang, Ralf B. Schittenhelm, Jennii Luu, Karla J. Cowley, Sung-Young Shin, Lan K. Nguyen, Terry C. C. Lim Kam Sian, Kimberley C. Clark, Kaylene J. Simpson, Xiuquan Ma, Roger J. Daly
Summary: We found that the expression of pseudokinase NRBP1 is associated with poor prognosis in triple negative breast cancer (TNBC). NRBP1 is required for efficient migration, invasion and proliferation of TNBC cells in culture, as well as growth of TNBC orthotopic xenografts and experimental metastasis. NRBP1 interacted with P-Rex1, Rac1, and Cdc42, and its overexpression enhanced levels of GTP-bound Rac1 and Cdc42 in a P-Rex1-dependent manner, leading to increased cell migration and invasion.
Article
Oncology
Ling Deng, Li Liao, Yin-Ling Zhang, Shu-Yuan Hu, Shao-Ying Yang, Xiao-Yan Ma, Min-Ying Huang, Fang-Lin Zhang, Da-Qiang Li
Summary: We found that U2SURP protein expression was significantly upregulated in TNBC tissues and associated with poor prognosis. U2SURP promoted alternative splicing of SAT1 pre-mRNA, resulting in increased stability of SAT1 mRNA and subsequent protein expression, thereby promoting the oncogenic properties of TNBC cells.
Article
Multidisciplinary Sciences
Yun-Song Yang, Xi Jin, Qin Li, Yi-Yu Chen, Fenfang Chen, Hena Zhang, Ying Su, Yi Xiao, Gen-Hong Di, Yi-Zhou Jiang, Shenglin Huang, Zhi-Ming Shao
Summary: This study explored the transcription variation landscape in triple-negative breast cancers (TNBCs) and identified a crucial oncogenic transcript MARCO-TST, which is associated with tumor progression and poor prognosis in TNBC patients. MARCO-TST enhances the stability of HIF-1 alpha by interacting with PLOD2, leading to metabolic dysregulation and the formation of a hypoxic tumor microenvironment in TNBC.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
(2022)
Article
Oncology
Li Liao, Ling Deng, Yin-Ling Zhang, Shao-Ying Yang, Lisa Andriani, Shu-Yuan Hu, Fang-Lin Zhang, Zhi-Min Shao, Da-Qiang Li
Summary: C9orf142 is elevated in TNBC patients and its elevation predicts unfavorable clinical outcome. C9orf142 promotes TNBC progression through transcriptional activation of MTBP to regulate its downstream MDM2/p53/p21 signaling axis. C9orf142 enhances resistance of TNBC cells to CDK4/6 inhibitor partially through MTBP/MDM2/p53/p21 signaling axis. Knockdown of C9orf142 inhibits TNBC progression and enhances its sensitivity to CDK4/6 inhibitor.
CLINICAL AND TRANSLATIONAL MEDICINE
(2023)
Article
Oncology
Duanyang Zhai, Mengmeng Zhang, Yuying Li, Jiong Bi, Xiaying Kuang, Zhen Shan, Nan Shao, Ying Lin
Summary: LINC01194 promotes the malignant progression of TNBC by recruiting NUMA1 to stabilize UBE2C mRNA. These findings may provide a more effective therapeutic strategy for TNBC patients.
Article
Biochemistry & Molecular Biology
Yesol Kim, Je Yeong Ko, Soo-Been Lee, Sumin Oh, Jee Won Park, Hyeok-Gu Kang, Da-Hyun Kim, Daeun Chung, Sera Lim, Hyunkyung Kong, Jongmin Kim, Kyung Hyun Yoo, Wonshik Han, Kyung-Hee Chun, Jong Hoon Park
Summary: The study identifies miR-371b-5p as a tumor-suppressive miRNA that regulates the CSDE1/Rac1 axis to inhibit the growth and invasion of TNBC cells. MiR-371b-5p has the potential to be a prognostic biomarker for TNBC.
Article
Medicine, Research & Experimental
Shufeng Ji, Hao Yu, Dan Zhou, Xulong Fan, Yan Duan, Yijiang Tan, Min Lang, Guoli Shao
Summary: This study used single-cell transcriptome sequencing to explore the role of the CHI3L1/MAF/CTLA4/S100A4 axis in immune escape in triple-negative breast cancer through interaction with breast cancer stem cells. The findings suggest that TN-BCSC-derived CHI3L1 upregulates CTLA4 expression in T cells, suppressing their function and promoting immune escape in TNBC.
JOURNAL OF TRANSLATIONAL MEDICINE
(2023)
Article
Oncology
Xiao Tong, Zhengling Yu, Jiani Xing, Haizhou Liu, Shunheng Zhou, Yu'e Huang, Jing Lin, Wei Jiang, Lihong Wang
Summary: The study investigated the potential of lncRNA HCP5-encoded peptide/protein and its role in triple-negative breast cancer. It was found that lncRNA HCP5 encodes a 132-amino acid sequence, known as HCP5-132aa, which promotes the growth of triple-negative breast cancer cells through ferroptosis regulation. Furthermore, breast cancer patients with elevated levels of HCP5-132aa had a worse prognosis.
Article
Oncology
Li Liao, Yin -Ling Zhang, Ling Deng, Chao Chen, Xiao-Yan Ma, Lisa Andriani, Shao-Ying Yang, Shu-Yuan Hu, Fang-Lin Zhang, Zhi-Min Shao, Da-Qiang Li
Summary: PPP1R14B is upregulated in TNBC and promotes cancer progression and paclitaxel resistance through maintaining the phosphorylation and stability of STMN1. It is a potential therapeutic target for TNBC.
Article
Cell Biology
Haiqin Zhang, Aiqin Gao, Qiaohong Liu, Fang Zhang, Shuyun Wang, Xiaozheng Chen, Wenjing Shi, Ye Zhang, Qian Liu, Yan Zheng, Yuping Sun
Summary: ILT4 is highly expressed in triple-negative breast cancer (TNBC) and promotes tumor progression by reprogramming glucose metabolism. Inhibition of ILT4 can attenuate TNBC progression and reduce the expression of glucose metabolism-related proteins.
JOURNAL OF CELL SCIENCE
(2023)
Article
Biochemistry & Molecular Biology
Linli Yao, Xiaonan Sheng, Xinrui Dong, Weihang Zhou, Ye Li, Xueyun Ma, Yonggang Song, Huijuan Dai, Yueyao Du
Summary: In this study, we found that neutrophil and neutrophil extracellular traps (NETs) were associated with tumor development in triple negative breast cancer (TNBC). The formation of NETs was higher in TNBC tissues and correlated with tumor size, ki67 level, and lymph node metastasis in TNBC patients. Inhibition of NETs suppressed TNBC tumor growth and lung metastasis, possibly through the oncogenic function of NETs dependent on TLR9 expression. Neutrophils from TNBC patients prone to form NETs enhanced the proliferation and invasion of TNBC cells, and NETs interaction with TLR9 decreased Merlin phosphorylation contributing to TNBC cell ferroptosis resistance.
Article
Environmental Sciences
Yuehua Li, Baohong Jiang, Lijun Zeng, Yuanbin Tang, Xiaowen Qi, Zhixing Wan, Wenjie Feng, Liming Xie, Rongfang He, Hongbo Zhu, Yimou Wu
Summary: Obesity is strongly associated with adverse prognosis in TNBC. Adipose-secreted exo-circCRIM1 promotes TNBC progression by inhibiting miR-503-5p and activating the OGA/FBP1 signaling pathway.
ENVIRONMENTAL RESEARCH
(2023)
Article
Oncology
Xu Zhang, Liang Shi, Han-Dong Sun, Zi-Wen Wang, Feng Xu, Ji-Fu Wei, Qiang Ding
Summary: In triple-negative breast cancer (TNBC), IGF2BP3 accelerates tumor cell proliferation through an m6A-dependent mechanism by destabilizing NF1. TET3 mediates promoter hypomethylation, leading to upregulation of IGF2BP3 expression. This suggests that IGF2BP3 could be a potential therapeutic target for TNBC.
CLINICAL AND TRANSLATIONAL MEDICINE
(2023)
Article
Multidisciplinary Sciences
Maria E. Gonzalez, Giuseppina Daniela Naimo, Talha Anwar, Alessandro Paoli, Shilpa R. Tekula, Suny Kim, Natasha Medhora, Shoshana A. Leflein, Jacob Itkin, Raymond Trievel, Kelley M. Kidwell, Yu-Chih Chen, Loredana Mauro, Euisik Yoon, Sebastiano Ando, Celina G. Kleer
Summary: This study uncovers the non-canonical function of EZH2 in promoting TNBC metastasis through phosphorylation at T367. It also reveals the ability of cytosolic EZH2 to methylate p38 alpha, enhancing its stability. Dual inhibition of EZH2 methyltransferase and p38 kinase activities can reduce TNBC growth and metastasis.
Article
Surgery
Natalie C. McClintock, Reed I. Ayabe, Ruben D. Salas Parra, Amy H. Kaji, Javier I. J. Orozco, Diego M. Marzese, Estela Samuels, Stacey L. Stern, Christine Dauphine, Junko J. Ozao-Choy
Summary: This study analyzed disparities in breast cancer patients at a county hospital and private hospital, revealing higher proportions of racial/ethnic minorities, younger ages, more aggressive tumors, and more advanced disease at the county hospital. These local disparities are largely consistent with national database studies, highlighting the need for further research into these differences.
Editorial Material
Oncology
Mary Garland-Kledzik, Adam Khader, Diego M. Marzese
ANNALS OF SURGICAL ONCOLOGY
(2022)
Editorial Material
Oncology
Mary Garland-Kledzik, Anthony Scholer, Miquel Ensenyat-Mendez, Javier I. J. Orozco, Adam Khader, Juan Santamaria-Barria, Trevan Fischer, Alessio Pigazzi, Diego M. Marzese
ANNALS OF SURGICAL ONCOLOGY
(2022)
Article
Oncology
Mary Garland-Kledzik, Anthony Scholer, Miquel Ensenyat-Mendez, Javier I. J. Orozco, Adam Khader, Juan Santamaria-Barria, Trevan Fischer, Alessio Pigazzi, Diego M. Marzese
Summary: This study identified five mutation subtypes of appendiceal cancer based on genetic mutations, with different mutation patterns and characteristics. The research also found that certain subtypes were less likely to be mucinous adenocarcinoma and that there were no significant differences in mutation frequencies between primary tumors and metastases in the assessed genes.
ANNALS OF SURGICAL ONCOLOGY
(2022)
Editorial Material
Dermatology
Matias A. Bustos, Dave S. B. Hoon
JOURNAL OF INVESTIGATIVE DERMATOLOGY
(2022)
Article
Cell Biology
Beiping Zhong, Bing Cheng, Xiaoming Huang, Qian Xiao, Zhitong Niu, Yu-feng Chen, Qiang Yu, Wenyu Wang, Xiao-Jian Wu
Summary: Cancer-associated fibroblasts (CAFs) play a crucial role in colorectal cancer (CRC) metastasis by inducing the expression of Leucine Rich Alpha-2-Glycoprotein 1 (LRG1), which promotes CRC migration and invasion through epithelial-mesenchymal transition (EMT). The CAFs-mediated IL-6-STAT3-LRG1 axis is responsible for the up-regulation of LRG1 in CRC, and higher LRG1 expression predicts poor clinical outcomes, especially distant metastasis free survival in CRC patients.
CELL DEATH & DISEASE
(2022)
Article
Oncology
Borja Sese, Sandra Iniguez-Munoz, Miquel Ensenyat-Mendez, Pere Llinas-Arias, Guillem Ramis, Javier I. J. Orozco, Silvia Fernandez de Mattos, Priam Villalonga, Diego M. Marzese
Summary: This study identifies a subpopulation of glioma stem cells (GSCs), known as core-GSCs (c-GSCs), in glioblastoma (GBM) patients that have a similar profile to embryonic stem cells (ESCs) and downregulated immune-associated pathways. The development of an induced c-GSC (ic-GSC) cellular model provides insights into the immune evasion mechanisms in GBM and potential targets for improving immunotherapy treatments.
Article
Multidisciplinary Sciences
Li-Teng Ong, Wee Chyan Lee, Shijun Ma, Gokce Oguz, Zhitong Niu, Yi Bao, Mubaraka Yusuf, Puay Leng Lee, Jian Yuan Goh, Panpan Wang, Kylie Su Mei Yong, Qingfeng Chen, Wenyu Wang, Adaikalavan Ramasamy, Dave S. B. Hoon, Henrik J. Ditzel, Ern Yu Tan, Soo Chin Lee, Qiang Yu
Summary: In this study, we discovered that IF‑β is highly expressed in HER2(+) breast cancer and inhibits the malignant characteristics of cancer cells by regulating the AKT signaling pathway and XBP1 activation.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
(2022)
Article
Dermatology
Sharmeen Chagani, Mariana P. De Macedo, Fernando Carapeto, Feng Wang, Diego M. Marzese, Khalida Wani, Lauren E. Haydu, Weiyi Peng, Giang T. Ong, Sarah E. Warren, Joseph M. Beechem, Dave S. B. Hoon, Gordon B. Mills, Michael T. Tetzlaff, Alexander J. Lazar, Lawrence N. Kwong, Michael A. Davies
Summary: Loss of PTEN protein expression in melanoma is associated with increased cancer aggressiveness, decreased tumor immune infiltration, and resistance to immune and targeted therapies.
JOURNAL OF INVESTIGATIVE DERMATOLOGY
(2023)
Article
Biochemistry & Molecular Biology
Jianfeng Chen, Jing Han Hong, Yulin Huang, Shini Liu, Jiaxin Yin, Peng Deng, Yichen Sun, Zhaoliang Yu, Xian Zeng, Rong Xiao, Jason Yongsheng Chan, Peiyong Guan, Yali Wang, Peili Wang, Lizhen Liu, Shijun Wen, Qiang Yu, Choon Kiat Ong, Bin-Tean Teh, Ying Xiong, Jing Tan
Summary: This study reveals that EZH2 plays an oncogenic role in ovarian cancer through noncatalytic activity. Inhibition of EZH2 degradation, rather than its catalytic activity, can effectively block ovarian cancer growth and tumor formation. Furthermore, EZH2 has extensive occupancy at promoters independent of PRC2 and can upregulate IDH2 to promote metabolic rewiring and contribute to ovarian cancer growth.
Review
Cell Biology
Bing Cheng, Qiang Yu, Wenyu Wang
Summary: Extensive studies in the last decade have shown that the tumor microenvironment (TME) is crucial in cancer development and therapeutic resistance. Within the TME, communication among tumor cells, stromal cells, immune cells, and noncellular components determines the fate of the tumor. Cancer-associated fibroblasts (CAFs), a common component, play pivotal roles in tumorigenesis, tumor progression, therapeutic response, and tumor immunity. Understanding the function of the TME, especially CAFs, is essential in tumor therapy.
JOURNAL OF BIOMEDICAL SCIENCE
(2023)
Article
Oncology
Satoru Furuhashi, Matias A. Bustos, Shodai Mizuno, Suyeon Ryu, Yalda Naeini, Anton J. Bilchik, Dave S. B. Hoon
Summary: The incidence of sporadic early-onset colon cancer (EOCC) has increased worldwide, but the molecular mechanisms in the tumor and tumor microenvironment (TME) are not fully understood. This study reveals the unique transcriptomic and proteomic profiles in tumor epithelial cells and cancer-associated fibroblasts (CAFs) in EOCC, and identifies the association between FAP(+) CAFs with upregulated WNT signaling and higher FGF20 levels at the tumor invasive margin.
NPJ PRECISION ONCOLOGY
(2023)
Article
Oncology
Yasunari Fukuda, Sun-Hee Kim, Matias A. Bustos, Sung-Nam Cho, Jason Roszik, Jared K. Burks, Hong Kim, Dave S. B. Hoon, Elizabeth A. Grimm, Suhendan Ekmekcioglu
Summary: The arachidonic acid pathway, specifically microsomal prostaglandin E2 synthase 1 (mPGES-1), plays important roles in regulating tumor immunity in melanoma. The study suggests that inhibiting mPGES-1 can reduce collagen deposition and T-cell exhaustion, thereby reinforcing immunotherapy in melanoma.
CANCER RESEARCH COMMUNICATIONS
(2023)
Article
Oncology
Wenyu Wang, Bing Cheng, Qiang Yu
Summary: The seed and soil concept has revolutionized cancer treatment in the past decade. The interaction between cancer cells and stromal cells, particularly cancer-associated fibroblasts (CAFs), plays a significant role in tumor progression and therapeutic resistance. Targeting CAFs is an emerging and promising strategy for anticancer therapies.
CANCER DRUG RESISTANCE
(2022)
Article
Medicine, Research & Experimental
Peng Deng, Zining Wang, Jinghong Chen, Shini Liu, Xiaosai Yao, Shaoyan Liu, Lizhen Liu, Zhaoliang Yu, Yulin Huang, Zhongtang Xiong, Rong Xiao, Jiuping Gao, Weiting Liang, Jieping Chen, Hui Liu, Jinghan Hong, Jason Yongsheng Chan, Peiyong Guan, Jianfeng Chen, Yali Wang, Jiaxin Yin, Jundong Li, Min Zheng, Chao Zhang, Penghui Zhou, Tiebang Kang, Bin Tean Teh, Qiang Yu, Zhixiang Zuo, Qingping Jiang, Jihong Liu, Ying Xiong, Xiaojun Xia, Jing Tan
Summary: In this study, RAD21 overexpression in ovarian cancer was found to be inversely correlated with IFN signature gene expression. RAD21 was shown to directly interact with YAP/TEAD4 and recruit NuRD complex to suppress IFN signaling. The study also demonstrated that RAD21 ablation enhanced the efficacy of anti-PD-1 treatment, suggesting RAD21 as a potential target and biomarker for precision immunotherapy in ovarian cancer.
JOURNAL OF CLINICAL INVESTIGATION
(2022)